EquityFolio

CELZ

NASDAQ Healthcare

Creative Medical Technology Holdings, Inc.

$0.53

-$0.09 (-14.35%)

Live quote

52w: $0.53 – $4.72

Loading chart…
P/E Ratio—
P/B Ratio0.58
EV/EBITDA—
Debt/Equity—
ROE-86.20%
ROIC—
Revenue Growth-45.45%
Gross Margin63.43%
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.

Own CELZ? Track it here.

Create a free account to add CELZ to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account